statistiche ricercatore

Continente	#
NA - Nord America	725
EU - Europa	355
AS - Asia	304
SA - Sud America	60
AF - Africa	19
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	1.465

Nazione	#
US - Stati Uniti d'America	714
IT - Italia	157
SG - Singapore	110
CN - Cina	72
BR - Brasile	48
HK - Hong Kong	39
RU - Federazione Russa	38
SE - Svezia	32
DE - Germania	31
VN - Vietnam	27
FR - Francia	19
FI - Finlandia	17
GB - Regno Unito	15
NL - Olanda	15
BD - Bangladesh	11
CI - Costa d'Avorio	9
IN - India	8
AR - Argentina	6
IQ - Iraq	6
JP - Giappone	6
CA - Canada	5
CZ - Repubblica Ceca	5
TR - Turchia	5
ZA - Sudafrica	5
AT - Austria	4
ID - Indonesia	4
PL - Polonia	4
CO - Colombia	3
ES - Italia	3
IE - Irlanda	3
LT - Lituania	3
MX - Messico	3
VE - Venezuela	3
BE - Belgio	2
ET - Etiopia	2
MY - Malesia	2
PK - Pakistan	2
SA - Arabia Saudita	2
UA - Ucraina	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BY - Bielorussia	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
IR - Iran	1
KG - Kirghizistan	1
MA - Marocco	1
MK - Macedonia	1
MZ - Mozambico	1
NP - Nepal	1
NZ - Nuova Zelanda	1
OM - Oman	1
PH - Filippine	1
RO - Romania	1
SC - Seychelles	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
Totale	1.465

Nome	#
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica"	268
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta	188
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort	185
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients	180
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results	160
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19	142
Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study	108
Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19	94
Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)	79
Galectin-3 and Neutrophil-to-Lymphocyte ratio are indicative of heart remodelling and disease severity in patients with Obstructive Sleep Apnoea	70
The impact of PAP therapy first impression on short-term treatment adherence	41
Totale	1.515

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	71	8	2	0	0	2	12	0	3	5	14	10	15
2022/2023	90	14	18	6	11	8	9	0	9	11	1	2	1
2023/2024	55	4	8	1	4	3	12	1	4	3	0	5	10
2024/2025	315	12	5	26	10	12	31	37	32	12	15	35	88
2025/2026	627	86	27	53	83	72	25	49	21	78	53	37	43
2026/2027	14	14	0	0	0	0	0	0	0	0	0	0	0
Totale													1.515